Designed free-lead composite shields for diagnostic medicine radiation fields by using MCNPX code
Authors
Abstract:
Introduction: Nowadays, applications of free-lead radiation shields are increased specially for weighting factor and toxicity of lead elements. Although touching the lead may be results in the nervousand blood system of body, it is not exactly proven yet. Protective measures are the fundamental parts of radiation protection. On the other hand, high weighting factor of lead shields are caused to fallow off using apron just in necessary situations. The primary principle of radiation protection is based on ALARA (As Low as Reasonable Achievable) law. Therefore, free-lead shields are attended of investigator. Three factors were proposed for designing radiation shields consist of: percent of attenuating against radiation in field, weight and cost. Choose of radiation shields are usually based on these three factors. Materials and Methods: In this study, attenuating factor, weight and cost are proposed for designing composite radiation shields. A source of radiation is collimated like X-ray machines in diagnostic medicine fields. The source has 90, 100 and 120keV spectrums that is output of IPEM78 software. The composite consists of the following eight elements. Tungsten(W), Barium(Br), Bismuth(Bi), Antimony(Sb), Cadmium(Cd), Cerium(Ce), Gadolinium(Gd) and Tin(Sn) are simulated by MCNPX code. The composites include one, two or three element with variant percentage. The dimension of each designed shield (composites and lead) in MCNPX code is 15*15*0.05cm3. Tallies F4 and F6 are applied for estimating local flux behind the shield. All the simulation codes with a standard deviation less than 0.5% are accepted. The relative flux of each composites is calculated by: Frel= Festimated/ Freal. Results: For composites which has two elements consist of W-Ce (55.16%-44.84%), W-Sb (52.38%- 47.62%) and W-Cd (31.25%-68.75%) are 63.4%, 50.4% and 47.7%, respectively. The relative flux of the composites with three elements consist of W-Ce-Cd (50%-30%-20%), W-Bi- Ce (45%-28%-27), W-Sn-Ce (46%-50%-4%), W-Sn-Cd (44%-50%-6%) and W-Sn-Bi (44%-50%- 6%) are Frel 58.1%, 55.9%, 51.6%, 49.5% and 49.2%, respectively. weight of These composites are equal to the weight of a common lead shield, while they have a higher attenuating factor. Conclusion: The results show that the pure elements have a better attenuating than oxide and sulfite of them in markets. If the cost wasn’t important, pure Gd could be good choice with the best attenuating factor. If an equipped laboratory was available, the composite with W could be the best choice with a reasonable cost. Optimization of these three factors depends on the importance of the factors.
similar resources
Simulation of gamma-ray gamma rays by composite shields compared to the lead protection using the MCNPX code
In this study, cobalt 60 with a mean energy of (1.25 Mev) was used as a photonic source to investigate the effect of decreasing gamma-ray intensity by materials and polymer composite using MCNPX code. First, we investigated the effect of thickness and density on the reduction of gamma ray intensity, and then the comparison between the lead protector, tungsten and polymer composite in several th...
full textApplication of personal non-lead nano-composite shields for radiation protection in diagnostic radiology: a systematic review and meta-analysis
composites with micro- and nano-metal fillers has attracted the attention of researchers for radiation shielding applications. Lead toxicity and heaviness have oriented extensive research toward the use of non-lead composite shields. The present study aimed to systematically review the efficiency of the composite shields of various micro- and nano-sized materials as composite shields have been ...
full textReview and Performance Comparison of Lead-Free Shields and Lead Shields, In Terms of Biological Effects in Nuclear Medicine by the Comet Method
Introduction: Ionizing radiation can cause damage to biologically important DNA molecules. Radiation in nuclear medicine radiation exposes people working in from two main positions; administer in gradiopharmaceuticals (the barn and squeezing a generator, procurement, distribution and drug infusion) and patients that receive radiation treatment (patients that are prescribed a ra...
full textDesign of Light Multi-layered Shields for Use in Diagnostic Radiology and Nuclear Medicine via MCNP5 Monte Carlo Code
Introduction Lead-based shields are the most widely used attenuators in X-ray and gamma ray fields. The heavy weight, toxicity and corrosion of lead have led researchers towards the development of non-lead shields. Materials and Methods The purpose of this study was to design multi-layered shields for protection against X-rays and gamma rays in diagnostic radiology and nuclear medicine. In this...
full textA Novel Design for Production of Efficient Flexible Lead-Free Shields against X-ray Photons in Diagnostic Energy Range
Background: Lead-based radiation shields are widely used in radiology departments to protect both workers and patients from any unnecessary exposure to ionizing radiation. Recently there has been a great deal of concern expressed about the toxicity of lead. Human lead toxicity is well documented. In that light, production of environmentally-friendly lead-free radiation shields with less weight ...
full textProton Therapy of eye using MCNPX code
Introduction: Proton radiotherapy is the one of advanced teletherapy methods. The protons deposit their maximum energy in a position called Bragg peak. Therefore, for treatment of cancer, the tumor should be placed at the Bragg peak or SOBP. The scattered photons and neutrons is a challenge in proton radiotherapy. The aim of this study is calculation of absorbed dose from scatt...
full textMy Resources
Journal title
volume 15 issue Special Issue-12th. Iranian Congress of Medical Physics
pages 461- 461
publication date 2018-12-01
By following a journal you will be notified via email when a new issue of this journal is published.
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023